Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma
Journal article published in 2017 by
M. Jebali,
R. Elaidi,
M. Brizard,
J. Fouque,
C. Takouchop,
B. Sabatier,
S. Oudard 
,
J. Medioni
,
J. Medioni
This paper is made freely available by the publisher.
Full text: Download
Data provided by 